ArticleInternational journal of biological sciences2026
A Novel PROTAC Confers a Dual Benefit Against Amyloid and Tau Pathology in Alzheimer's Disease via DAPK1 Degradation.
Ruomeng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.